FNY Investment Advisers LLC Raises Stock Position in Teradyne, Inc. $TER

FNY Investment Advisers LLC boosted its holdings in shares of Teradyne, Inc. (NASDAQ:TER) by 150.1% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,501 shares of the company’s stock after purchasing an additional 1,501 shares during the period. FNY Investment Advisers LLC’s holdings in Teradyne were worth $1,210,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently added to or reduced their stakes in TER. State Street Corp lifted its holdings in shares of Teradyne by 0.9% in the 4th quarter. State Street Corp now owns 7,078,635 shares of the company’s stock valued at $1,370,141,000 after buying an additional 60,986 shares during the period. Ameriprise Financial Inc. boosted its stake in shares of Teradyne by 3.0% in the second quarter. Ameriprise Financial Inc. now owns 4,920,100 shares of the company’s stock worth $442,413,000 after buying an additional 143,058 shares during the last quarter. Price T Rowe Associates Inc. MD grew its holdings in Teradyne by 18.6% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 4,203,546 shares of the company’s stock worth $813,640,000 after acquiring an additional 659,273 shares during the period. Invesco Ltd. grew its holdings in Teradyne by 3.5% during the third quarter. Invesco Ltd. now owns 2,959,330 shares of the company’s stock worth $407,322,000 after acquiring an additional 99,864 shares during the period. Finally, Morgan Stanley raised its position in Teradyne by 1.9% during the fourth quarter. Morgan Stanley now owns 2,442,014 shares of the company’s stock valued at $472,677,000 after acquiring an additional 45,089 shares in the last quarter. 99.77% of the stock is owned by hedge funds and other institutional investors.

Teradyne Stock Performance

TER opened at $384.89 on Friday. The stock has a market capitalization of $60.17 billion, a PE ratio of 52.80, a P/E/G ratio of 0.79 and a beta of 1.78. Teradyne, Inc. has a one year low of $104.58 and a one year high of $487.91. The business’s 50 day moving average price is $383.36 and its 200 day moving average price is $342.29.

Teradyne (NASDAQ:TER) last issued its quarterly earnings data on Tuesday, July 28th. The company reported $2.47 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.09 by $0.38. Teradyne had a return on equity of 39.93% and a net margin of 25.77%.The firm had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.22 billion. During the same period last year, the company earned $0.57 EPS. The company’s quarterly revenue was up 103.9% on a year-over-year basis. Teradyne has set its Q3 2026 guidance at 1.850-2.150 EPS. As a group, equities research analysts forecast that Teradyne, Inc. will post 9.1 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Teradyne news, insider Shannon John Poulin sold 656 shares of Teradyne stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $355.00, for a total value of $232,880.00. Following the completion of the transaction, the insider directly owned 15,722 shares of the company’s stock, valued at $5,581,310. The trade was a 4.01% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Gregory Stephen Smith sold 4,000 shares of Teradyne stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $423.03, for a total value of $1,692,120.00. Following the completion of the transaction, the chief executive officer directly owned 120,470 shares of the company’s stock, valued at approximately $50,962,424.10. This represents a 3.21% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 14,261 shares of company stock valued at $5,187,344 over the last ninety days. Insiders own 0.19% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the company. UBS Group upped their price objective on Teradyne from $440.00 to $500.00 and gave the stock a “buy” rating in a research report on Monday, July 20th. The Goldman Sachs Group reaffirmed a “buy” rating and set a $465.00 target price on shares of Teradyne in a report on Tuesday, July 28th. Citigroup upped their price objective on shares of Teradyne from $325.00 to $400.00 and gave the stock a “buy” rating in a research report on Thursday, April 30th. Morgan Stanley upped their target price on Teradyne from $387.00 to $397.00 and gave the stock an “equal weight” rating in a research note on Thursday, July 30th. Finally, Weiss Ratings lowered shares of Teradyne from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, July 20th. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, Teradyne has a consensus rating of “Moderate Buy” and an average price target of $396.80.

Teradyne Company Profile

Teradyne, Inc is a global supplier of automatic test equipment and related services principally used to test semiconductors, wireless products and complex electronic systems. Founded in 1960, the company is headquartered in North Reading, Massachusetts, and has a long history of developing capital equipment and software that help semiconductor manufacturers, electronics OEMs and contract manufacturers validate product performance and reliability during design and production.

The company’s product portfolio centers on automatic test equipment (ATE) and system-level test solutions that address chip- and board-level validation, burn-in and reliability screening.